李瑞娟 - 内蒙古医科大学

个人简介

2005.09-2009.07 内蒙古医科大学药学院，药物制剂专业，本科 2009.09-2010.07 沈阳药科大学制药工程学院，药物化学专业，硕士 2010.08-2012.07 军事医学科学院药物毒物研究所，药物化学专业，硕士 2012.09-2015.07 沈阳药科大学制药工程学院，药物化学专业，博士 2015.09-至今内蒙古医科大学药学院，药剂学教研室，讲师

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

1、Rui-Juan Li, Jian Wang, Zhen Xu, Wan-Xu Huang, Jia Li, Sheng-Fei Jin, Dong-Mei Zhao, Mao-Sheng Cheng. Computational Insight into p21-Activated Kinase 4 Inhibition: A Combined Ligand- and Structure-Based Approach. ChemMedChem, 9 (2014) 1012–1022. (2014IF: 3.046) 2、Ruijuan Li, Xiaolin Su, Zheng Chen, Wanxu Huang, Yali Wang, Kaibo Wang, Bin Lin, Jian Wang, Maosheng Cheng. Structure-based virtual screening and ADME/T-based profiling for low molecular weight chemical starting points as p21-activated kinase 4 inhibitors. RSC Advances, 5 (2015), 23202-23209. (2015IF: 3.84) 3、Ruijuan Li (co-first author), Yali Wang (co-first author), Qinghe Wang, Jian Wang, Maosheng Cheng. In Silico Design of human IMPDH inhibitors using pharmacophore Mapping and Molecular docking Approaches.Computational and Mathematical Methods in Medicine, 2015 (2015) 11. (2015IF: 0.766) 4、Ruijuan Li (co-first author), Yali Wang (co-first author), Qinghe Wang, Wanxu Huang, Jian Wang, Maosheng Cheng. Binding mode of inhibitors and Cryptosporidium parvum IMP Dehydrogenas: A combined ligand- and target-based study. SAR and QSAR in environmental research,26 (2015) 421-438 (2015IF: 1.596)